Effects of Physical Activity in Patients With Diabetes
Effects of Physical Activity Counseling and Pilates Exercises on Metabolic Control Variables in Patients With Prediabetes and Type 2 Diabetes:Randomised Controlled Study
1 other identifier
interventional
90
1 country
1
Brief Summary
The primary aim of our study is to evaluate the effects of physical activity counseling and pilates exercises on metabolic control variables in patients with prediabetes and type 2 diabetes; Its secondary aim is to examine the effects of both practices on physical activity level, exercise capacity and quality of life, and to compare the relationship between those under medical supervision by family doctor.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable diabetes-mellitus
Started Oct 2020
Typical duration for not_applicable diabetes-mellitus
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 4, 2020
CompletedStudy Start
First participant enrolled
October 30, 2020
CompletedFirst Posted
Study publicly available on registry
November 25, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 12, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2023
CompletedOctober 26, 2024
May 1, 2023
2.2 years
October 4, 2020
October 22, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (9)
fasting blood glucose
A fasting blood sugar level less than 100 mg/dL (5.6 mmol/L) is normal. A fasting blood sugar level from 100 to 125 mg/dL (5.6 to 6.9 mmol/L) is considered prediabetes. If it's 126 mg/dL (7 mmol/L) or higher on two separate tests, you have diabetes percentage of body fat, amount of visceral fat, body mass index: amount of muscle mass in the trunk and extremities
up to 12 weeks
HbA1c
A hemoglobin A1c (HbA1c) test measures the amount of blood sugar (glucose) attached to hemoglobin. Normal: HbA1c below 5.7% Prediabetes: HbA1c between 5.7% and 6.4% Diabetes: HbA1c of 6.5% or higher
up to 12 weeks
HDL
HDL (high-density lipoprotein cholesterol) cholesterol: High density lipoprotein cholesterol.60 mg/dL (1.6 mmol/L) or above is desirable
up to 12 weeks
LDL
LDL (low-density lipoprotein cholesterol) Adult - \< 130 mg/dL is normal value for LDL. Low-density lipoprotein is a type of lipoprotein that consists of cholesterol (LDL cholesterol, LDL-C) and similar substances with a small amount of protein
up to 12 weeks
total cholesterol
Total cholesterol a measure of the total amount of cholesterol in your blood. It includes both low-density lipoprotein (LDL) cholesterol and high-density lipoprotein (HDL) cholesterol. Less than 200 mg/dL is normal
up to 12 weeks
triglyceride values
Triglycerides are a type of fat (lipid) found in blood. Normal is less than 150 milligrams per deciliter (mg/dL), or less than 1.7 millimoles per liter (mmol/L)
up to 12 weeks
percentage of body fat
Body fat percentage will be calculated with the Jawon X-Contact 350 device
up to 12 weeks
Muscle mass amounts in the trunk and extremities
Muscle mass amounts in the trunk and extremities will be calculated with the Jawon X-Contact 350.Muscle mass includes the skeletal muscles, smooth muscles such as cardiac and digestive muscles and the water contained in these muscles
up to 12 weeks
Step number
Average one week steps before and after intervention will be calculated with OMRON HJ 109 pedometer
up to 12 weeks
Secondary Outcomes (9)
Short version of IPAQ (International Physical Activity Questionnaire)
up to 12 weeks
SF36 (Short Form 36)
up to 12 weeks
6 minutes walk test
up to 12 weeks
BMI (body mass index)
up to 12 weeks
amount of visceral fat
up to 12 weeks
- +4 more secondary outcomes
Study Arms (3)
Experimental group 1
EXPERIMENTALphysical activity counseiling +pilates exercise group
Experimental group 2
EXPERIMENTALonly physical activity counseiling group
Control Group
NO INTERVENTIONonly followed by family physician
Interventions
It is planned to do the pilates exercises for 50 minutes a day, 2 days a week during 12 weeks with physiotherapist. Pilates group patient will make pilates exercise once a week alone During physical activity counseling, considering the current physical and metabolic status of the person, the person-based 5A model of ACSM will be adapted to individuals with diabetes and physical activity consultancy will be provided
During physical activity counseling, considering the current physical and metabolic status of the person, the person-based 5A model of ACSM will be adapted to individuals with diabetes and physical activity consultancy will be provided. Patients make aerobic and strengthening exercises by theirself based on phyiotherapist's suggestions
Eligibility Criteria
You may qualify if:
- Having been diagnosed with prediabetes or Type II diabetes at most 10 years ago
- Not using insulin
- Being under the age of 70
- Be woman
- Individuals regulated by glucose control, medication and / or diet
- Volunteering to exercise at least 3 days a week in the intervention group within the scope of the research
- Being able to communicate in Turkish written and verbal
You may not qualify if:
- Having uncontrolled hypertension (160/90 mmHg), cardiovascular problem, renal disease, neuropathy, systemic disease that will create contraindications for exercise
- Body mass index over 35 kg / m²
- Being a communication problem, not being able to cooperate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Merve Suay
Hatay, 31350, Turkey (Türkiye)
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
ela tarakcı, prof dr
Istanbul University- Cerrahpasa Physiotherpy and Rehabilitation Department
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principal investigator
Study Record Dates
First Submitted
October 4, 2020
First Posted
November 25, 2020
Study Start
October 30, 2020
Primary Completion
January 12, 2023
Study Completion
June 1, 2023
Last Updated
October 26, 2024
Record last verified: 2023-05
Data Sharing
- IPD Sharing
- Will not share